REMSIMA 40mg / ml concentrate for solution for infusion medication leaflet

L04AB02 • infliximab • Antineoplastic and immunomodulating agents | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors

Infliximab is a monoclonal antibody used to treat autoimmune inflammatory diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, or ankylosing spondylitis. It works by blocking tumor necrosis factor-alpha (TNF-α), reducing inflammation and associated symptoms.

The medication is administered intravenously under the supervision of a specialist, usually at regular intervals.

Side effects may include infusion site reactions, infections, headaches, or fatigue. In rare cases, severe allergic reactions or serious infections may occur.

Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.